A 200-μg, controlled-release misoprostol vaginal insert reduced median time to vaginal delivery by 11.3 hours compared with another prostaglandin, but it also increased the rate of uterine ...

Misoprostol is FDA-approved to reduce the risk of gastric stomach ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) in adults. It’s available as the brand-name drug Cytotec. Misoprostol ...

H.L. is a 25-year-old woman, gravida 2 para 1-0-0-0 admitted to the birth unit at 38 and 6/7 weeks' gestation for induction of labor because of an obstetric history of a previous intrauterine fetal ...